Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.097 | 0.003 |
mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.005 |